US 11795234
Methods of producing muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
granted A61KA61K2039/505A61K47/6807
Quick answer
US patent 11795234 (Methods of producing muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide) held by Dyne Therapeutics, Inc. expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K47/6807, A61K47/6849, A61K47/6889